PIPELINE
Staidson’s several molecules are in various stages of discovery and preclinical development.
| Program | Indications | Discovery | Preclinical/IND-Enabling | Phase I (2021) | Phase II | Phase III |
|---|---|---|---|---|---|---|
| STSA-1005 | COVID-19/Autoimmune | |||||
| SB-1901 | Immuno-Oncology | |||||
| SB-2003 | Immuno-Oncology | |||||
| SB-1802 | Autoimmune Diseases | |||||
| SB-1902 | Immuno-Oncology | |||||
| SB-2001 | Immuno-Oncology | |||||
| SB-2002 | Immuno-Oncology |